» Articles » PMID: 20147780

Identification of MiRNAs That Are Associated with Tumor Metastasis in Neuroblastoma

Overview
Specialties Oncology
Pharmacology
Date 2010 Feb 12
PMID 20147780
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The discovery of microRNAs (miRNAs) has opened a new avenue for both diagnosis and treatment of cancers. Accumulating experimental evidences indicate that miRNAs are aberrantly expressed in different tumor types and have a critical role in tumorigenesis. However, the miRNA expression profile in neuroblastoma (NB), one of the most common cancer forms in children, has not been well characterized. In the present study, we established a heterotopic transplant mice model of NB and employed miRNA microarray analysis to identify miRNAs that are differentially expressed in metastatic NB compared to primary NB. A list of 54 miRNAs was found to be significantly altered in metastatic tumors compared to primary tumors. These differentially-expressed miRNAs were selectively validated by a stem-loop qRT-PCR assay. Furthermore, we predicted a list of potential miRNA-target pairs that may be involved in the metastasis of neuroblastoma by three different computer-aided algorithms. Taken together, our results indicate that a unique panel of miRNAs are associated with metastatic NB and these differentially-expressed miRNAs may play an important role in the NB metastatic process. This finding may also shed light in our understanding of the nature of metastatic NB and provide a potential novel target for therapeutic treatment of this tumor.

Citing Articles

Unsaturated Fatty Acid Synthesis Is Associated with Worse Survival and Is Differentially Regulated by and Tumor Suppressor microRNAs in Neuroblastoma.

Sheeter D, Garza S, Park H, Benhamou L, Badi N, Espinosa E Cancers (Basel). 2024; 16(8).

PMID: 38672672 PMC: 11048984. DOI: 10.3390/cancers16081590.


Longitudinal evaluation of serum microRNAs as biomarkers for neuroblastoma burden and therapeutic p53 reactivation.

Van Goethem A, Deleu J, Yigit N, Everaert C, Moreno-Smith M, Vasudevan S NAR Cancer. 2023; 5(1):zcad002.

PMID: 36683916 PMC: 9846426. DOI: 10.1093/narcan/zcad002.


A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors.

Sromek M, Rymkiewicz G, Paziewska A, Szafron L, Kulecka M, Zajdel M Biomolecules. 2021; 11(9).

PMID: 34572608 PMC: 8466839. DOI: 10.3390/biom11091395.


miR-483-3p promotes proliferation and migration of neuroblastoma cells by targeting PUMA.

Wu K, Wang J, He J, Chen Q, Yang L Int J Clin Exp Pathol. 2020; 11(2):490-501.

PMID: 31938135 PMC: 6958035.


miR-373 promotes neuroblastoma cell proliferation, migration, and invasion by targeting SRCIN1.

Yuan X, Wen F, Chen X, Jiang X, Liu S Onco Targets Ther. 2019; 12:4927-4936.

PMID: 31417287 PMC: 6593744. DOI: 10.2147/OTT.S205582.